CoChat

Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening

Salerno, M, Micillo, M, Di Maio, S, Capalbo, D, Ferri, P, Lettiero, T, Tenore, A · 2001 · European Journal of Endocrinology

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To evaluate longitudinal growth, pubertal development and final height in patients with congenital hypothyroidism (CH) detected by a neonatal screening programme, and to identify factors potentially affecting growth outcome. PATIENTS: Fifty-five patients (41 females) detected by neonatal screening and followed longitudinally from the time of diagnosis and treatment (25+/-5 days) up to the age of 17+/-0.5 years were evaluated retrospectively. RESULTS: Pubertal development began and progressed normally in both males and females. In boys, a testicular volume of 4 ml was reached at 11.3+/-1.0 years. In girls breast enlargement (B2) occurred at a mean age of 10.3+/-1.2 years and the mean age of menarche was 12.5+/-1.2 years. The onset and the progression of puberty were independent of the aetiology, the severity of CH and the timing of the beginning of treatment. Girls treated with an initial amount of L-thyroxine (L-T4) greater than 8 microg/kg per day showed an earlier onset of puberty (B2 9.4+/-0.9 years; menarche 11.5+/-0.8 years) compared with girls treated with a lower initial dose of L-T4 (B2 10.5+/-1.2 years; menarche 12.6+/-1.2 years; P<0.02). However, both groups attained a similar final height (-0.1+/-1.0 SDS and 0.4+/-1.0 SDS, respectively), which in both cases was above the target height (P=0.03). All the patients in the study attained a mean final height (0.1+/-1.1 SDS) within the normal range for the reference population and above the target height (-0.9+/-0.9 SDS, P<0.0001). No significant relationship was found between final height and severity of CH at diagnosis, initial L-T4 dosage or aetiology of the defect. Patients with ectopic gland, thyroid aplasia or in situ gland attained a similar mean final height (0.1+/-1.1 SDS, 0.5+/-1.0 SDS and -0.5+/-1.0 SDS, respectively), which was in all cases greater than target height (-1.0+/-0.9, -0.6+/-0.8, -0.9+/-0.8 respectively; P<0.05). CONCLUSIONS: Our results suggest that conventional management of children with CH detected by neonatal screening leads to normal sexual development and normal adult height, and that the major factor determining height in these children is familial genetic growth potential.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje.0.1450377

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 123

Metadata

Authors
Salerno, M., Micillo, M., Di Maio, S., Capalbo, D., Ferri, P., Lettiero, T., & Tenore, A.
Affiliations
  • Federico II University Hospital (IT)
  • University of Udine (IT)
Corresponding author
Salerno, M
Venue
European Journal of Endocrinology
Published
2001-10-01
Volume
145
Issue
4
Pages
377-383
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2121049840
Cited by
123
References
21
Citations by year
2025: 8 · 2024: 3 · 2023: 2 · 2022: 10 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 2 · 2016: 11 · 2015: 7 · 2014: 4 · 2013: 4 · 2012: 3
FWCI
2.48
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Society for Paediatric Endocrinology
  • European Society of Endocrinology
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
congenital hypothyroidism, newborn screening, linear growth, pubertal development, adult height, thyroid hormone replacement, ectopic thyroid tissue, menarche, breast development, testicular volume, target height, children and adolescents
MeSH terms
Body Height, Bone Development, Child Development, Congenital Hypothyroidism, Dose-Response Relationship, Drug, Female, Humans, Hypothyroidism, Infant, Newborn, Longitudinal Studies, Male, Puberty, Reference Values, Sexual Maturation, Thyroxine, Neonatal Screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.